Carerx Corporation · TSX:CRRX
Carerx — Q3 2020 Earnings Presentation
15 slides from Carerx's earnings presentation, Nov 6, 2020
Slide 1: Q3 2020 Earnings Call
Slide 2: Forward Looking Statements
Forward Looking Statements Certain of the statements contained in this presentation are "forward looking information within the meaning of applicable Canadian securities legislation. Forward looking information includes, but is not limited to, business strategy, plans and other expectations, beliefs
Slide 3: David Murphy, President & Chief Executive Officer
David Murphy President & Chief Executive Officer
Slide 4: Continuing strong financial results and significant progress on Remedy's integration
Q3 2020 Continuing strong financial results + Significant progress on Remedy’s integration
Slide 5: Q3 2020 Financial Highlights
Q3 2020 Financial Highlights Continuing Operations (millions except margin) (+/- compared to Q3 2019) Revenue $45.6 +45% Average Beds Serviced 49,344 +58% Adjusted EBITDA $3.8 +37% First full quarter of revenue contribution from Remedy’s — minimal contribution from integration synergies Adjusted EBI
Slide 6: Significant Progress on Remedy's Integration
Significant Progress on Remedy’s Integration Commenced consolidation of certain fulfillment centres Primary driver of cost synergies | nteg ration is ad hea d 4 fulfillment centres closed to date of schedule and will 5 subsequent to quarter end be com pleted by 3 centres still to be closed the end o
Slide 7: Andrew Mok, Chief Financial Officer
Andrew Mok Chief Financial Officer
Slide 8: Q3 2019 vs Q3 2020
50 • 45 40 • 35 30 25 • 20 15 10 5 0 Q3 2019 Q3 2020
Slide 9: Q3 2020 Financial Results | Adjusted EBITDA
Q3 2020 Financial Results | Adjusted EBITDA Nh Bb $2.8 Q3 2019 (millions) $3.8 Q3 2020 37% year-over-year growth Remedy’s contributed $1.2 million Net impact of ODBA amendments reduced Adjusted EBITDA by $0.3 million Reduced corporate costs by 15% Reduced other operating costs by $0.2 million
Slide 10: Balance Sheet and Cash Flows
Balance Sheet and Cash Flows (millions except ratio) At Sept. 30/20 Cash $18.3 Net Debt! $39.1 Net Debt to Adjusted EBITDA? 2.6 X Q3 2020 Cash provided by $15 operations? Subsequent to quarter end, divested of a shell, non-operating subsidiary * Pre-1954 charter company * Gross proceeds of $1.5 mill
Slide 11: David Murphy, President & Chief Executive Officer
David Murphy President & Chief Executive Officer a
Slide 12: Growth Strategy Provides Opportunity for Significant Shareholder Value
Growth Strategy Provides Opportunity for Significant Shareholder Value 12 Increase beds under contract Well capitalized and positioned to win significant new RFPs and contracts Consolidate the market Highly fragmented market provides opportunities for accretive acquisitions to increase scale and rea
Slide 13: Strengthened Senior Management Team
Strengthened Senior Management Team 13 Added Puneet Khanna as SVP, Corporate Development Extensive industry experience and deep relationships Proven track record of building strong business relationships and driving growth Former CEO of MED e-care Health Solutions More than a decade with Medical Pha
Slide 14: CareRx
Ss» CareRx Large, fast-growing Existing, scalable Organic growth and seniors market national platform acquisition opportunities www.carerx.cda
Slide 15: Questions
J *.. Questions Visit our website at www.carerx.ca | Follow @CareRx on Twitter $$ CareRx